Mark J. Tarr

This profile gathers the share dealings of Mark J. Tarr in Encompass Health Corp, where the filings describe the role as chief executive. In total, 98 filings cover trades dated from 4 January 2016 to 10 August 2026.

In open-market terms, that means 1 purchase worth €227k on one side and 22 sales worth €61.2M on the other. Netting one side against the other leaves €61.0M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 60 share grants and 15 option exercises. In 2026 alone, the filings show no purchases and 9 sales.

The newest entry dates from 11 August 2026: an open-market sale of €18.6M, in Encompass Health Corp. The most recent open-market purchase was published on 14 November 2016, 3,630 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.